Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765487
Status:
RECRUITING
Last Update Posted:
2024-01-11
First Post:
2023-03-01
Brief Title:
Using Thermography to Assess the Affects of Sildenafil Cream 36
Sponsor:
Daré Bioscience Inc
Organization:
Daré Bioscience Inc
Study Overview
Official Title:
Phase 1 Single-Dose Double-Blind Vehicle-Controlled 3-Way Crossover Study Using Thermography to Assess the Pharmacodynamics and Pharmacokinetics of L-Arginine and Sildenafil Contained in Sildenafil Cream 36 in Normal Healthy Premenopausal Women
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to compare thermography images in normal healthy premenopausal women after the application of Sildenafil Cream 36 L-arginine cream and placebo cream Participants will be shown a series of explicit videos to elicit a change in genital temperature before and after application of cream
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None